chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Blood brain barrier defect, Condition aggravated, Confusional state, Immunisation, Incoherent
Clinical narrative: Booster; Woke up confused; Unable to stop Shaking; spinal meningitis; Broke the blood brain barrier and infected him; He progressively Got worse; He had lost all motor skills; infected him; incoherent speech; This is a spontaneous report from a contactable consumer (reporters father).  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 3 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose (booster) for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient received BNT162B2, dose 1 and then dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. A few days after the booster, the patient woke up confused and unable to stop shaking, he was admitted to Hospital. The patient progressively got worse, he had no idea where he was and he had lost all motor skills except speech but he was incoherent. After a few nights fearing the worst the antivirals he was given began to work and he stabilized and regressed several times. After a week he was diagnosed with spinal meningitis. The booster broke the blood brain barrier and infected him. The patient was not recovered from the events confusion and shaking while the outcome of the other events was unknown.   The patient underwent lab tests and procedures which included investigation: spinal meningitis was diagnosed on an unspecified date.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19
Symptoms: Infection, Investigation, Meningitis, Motor dysfunction, Tremor
Clinical narrative: Booster; Woke up confused; Unable to stop Shaking; spinal meningitis; Broke the blood brain barrier and infected him; He progressively Got worse; He had lost all motor skills; infected him; incoherent speech; This is a spontaneous report from a contactable consumer (reporters father).  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 3 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose (booster) for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient received BNT162B2, dose 1 and then dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. A few days after the booster, the patient woke up confused and unable to stop shaking, he was admitted to Hospital. The patient progressively got worse, he had no idea where he was and he had lost all motor skills except speech but he was incoherent. After a few nights fearing the worst the antivirals he was given began to work and he stabilized and regressed several times. After a week he was diagnosed with spinal meningitis. The booster broke the blood brain barrier and infected him. The patient was not recovered from the events confusion and shaking while the outcome of the other events was unknown.   The patient underwent lab tests and procedures which included investigation: spinal meningitis was diagnosed on an unspecified date.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Interchange of vaccine products, Off label use, Oropharyngeal pain
Clinical narrative: I tested positive for Covid 3 days later on 08Nov2021; chills; body aches; nasty cough; sore throat; runny nose; Patient received J&J one shot on 12Mar2021 and received the Pfizer Booster Vaccine on 05Nov2021; Patient received J&J one shot on 12Mar2021 and received the Pfizer Booster Vaccine on 05Nov2021; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 54-years-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: FH 8020), via an unspecified route of administration, administered in Arm Left on 05Nov2021 (at the age of: 54-years-old) as dose 2 (initial pfizer dose), single for covid-19 immunisation. The patient medical history was not reported. The patient received concomitant medications with several prescription medications & vitamins. The patient had no known allergies. The patient was not a pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to covid vaccination. The vaccine facility type was pharmacy or drug store. The patient previously received first dose of J&J One Shot (JANSSEN COVID-19 VACCINE, Lot number: 1805022), via an unspecified route of administration, administered in Arm right on 12Mar2021 (at the age of: 54-years-old) as dose 1 for covid-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received first dose of vaccine with J&J one shot on 12Mar2021 and received second dose of vaccine with bnt162b2 on 05Nov2021. It was reported that she received the Pfizer Booster Vaccine on 05Nov2021 and shortly thereafter experienced not just the common side effects of chills and body aches, but also a nasty cough, sore throat and runny nose. she tested positive for Covid 3 days later on 08Nov2021. The patient underwent lab tests and procedures which included sars-cov-2 test with positive on 08Nov2021 Nasal Swab. The patient did not receive the treatment for the events. Since the vaccination, the patient had been tested for COVID-19. The outcome of the events was recovering.  Follow-Up (16Nov2021): Follow-up attempts are completed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: I tested positive for Covid 3 days later on 08Nov2021; chills; body aches; nasty cough; sore throat; runny nose; Patient received J&J one shot on 12Mar2021 and received the Pfizer Booster Vaccine on 05Nov2021; Patient received J&J one shot on 12Mar2021 and received the Pfizer Booster Vaccine on 05Nov2021; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 54-years-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: FH 8020), via an unspecified route of administration, administered in Arm Left on 05Nov2021 (at the age of: 54-years-old) as dose 2 (initial pfizer dose), single for covid-19 immunisation. The patient medical history was not reported. The patient received concomitant medications with several prescription medications & vitamins. The patient had no known allergies. The patient was not a pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to covid vaccination. The vaccine facility type was pharmacy or drug store. The patient previously received first dose of J&J One Shot (JANSSEN COVID-19 VACCINE, Lot number: 1805022), via an unspecified route of administration, administered in Arm right on 12Mar2021 (at the age of: 54-years-old) as dose 1 for covid-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received first dose of vaccine with J&J one shot on 12Mar2021 and received second dose of vaccine with bnt162b2 on 05Nov2021. It was reported that she received the Pfizer Booster Vaccine on 05Nov2021 and shortly thereafter experienced not just the common side effects of chills and body aches, but also a nasty cough, sore throat and runny nose. she tested positive for Covid 3 days later on 08Nov2021. The patient underwent lab tests and procedures which included sars-cov-2 test with positive on 08Nov2021 Nasal Swab. The patient did not receive the treatment for the events. Since the vaccination, the patient had been tested for COVID-19. The outcome of the events was recovering.  Follow-Up (16Nov2021): Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chest discomfort, Dyspnoea, Headache, Pyrexia
Clinical narrative: Fever of 101f; Chest congestion; Headache; Trouble with breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient himself).  A male patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 28Oct2021 as dose number unknown (booster), single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever of 101f within 24 hours, first week result in severe chest congestion and trouble with breathing, headache, trouble with breathing on an unspecified date in Oct2021. The patient underwent lab tests and procedures which included body temperature: 101 Fahrenheit on Oct2021. She took over the counter drugs for the resulted events. She finally had return to almost normal condition after two weeks. The outcome of events was recovered on an unspecified date in Nov2021.   Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Dyspnoea, Headache, Immunisation, Pyrexia
Clinical narrative: Fever of 101f; Chest congestion; Headache; Trouble with breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient himself).  A male patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 28Oct2021 as dose number unknown (booster), single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever of 101f within 24 hours, first week result in severe chest congestion and trouble with breathing, headache, trouble with breathing on an unspecified date in Oct2021. The patient underwent lab tests and procedures which included body temperature: 101 Fahrenheit on Oct2021. She took over the counter drugs for the resulted events. She finally had return to almost normal condition after two weeks. The outcome of events was recovered on an unspecified date in Nov2021.   Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion
Clinical narrative: Fever of 101f; Chest congestion; Headache; Trouble with breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient himself).  A male patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 28Oct2021 as dose number unknown (booster), single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever of 101f within 24 hours, first week result in severe chest congestion and trouble with breathing, headache, trouble with breathing on an unspecified date in Oct2021. The patient underwent lab tests and procedures which included body temperature: 101 Fahrenheit on Oct2021. She took over the counter drugs for the resulted events. She finally had return to almost normal condition after two weeks. The outcome of events was recovered on an unspecified date in Nov2021.   Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: a bit tired; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date were not reported) via an unspecified route of administration, on unspecified date, as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, after taking Pfizer COVID vaccine, the patient felt a bit tired. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Breakthrough, positive for COVID-19; Breakthrough, positive for COVID-19; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6204, Expiration date: unknown) via an unspecified route of administration, administered at unspecified anatomical location on 23Mar2021 (age at vaccination was 40 years) as dose 2, single and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6198, Expiration date: unknown) via an unspecified route of administration, administered at unspecified anatomical location on 02Mar2021 (age at vaccination was 40 years) as dose 1, single for COVID-19 immunization. The patient had had allergic reaction included hives and rash to the Regen-COV2 antibody infusion. Concomitant medications were not reported. On 02Nov2021, the patient experienced breakthrough, positive for COVID-19 (vaccination failure) showing symptoms of fever, cough, chills and head cold. The seriousness of the events were medically significant and hospitalization. The duration of hospitalization was 1 day. The adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care and hospitalization. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab test) with positive results on 02Nov2021. The patient was treated at hospital with Rengen-COV2 antibody infusion therapy 1 day after positive test result. Patient showed allergies towards infusion and only received 70ml of the 100ml dose of antibodies. Patient was given steroids and Benadryl and monitored. The outcome of event was recovering.  Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Body temperature, COVID-19, Headache
Clinical narrative: Breakthrough COVID-19; Breakthrough COVID-19/She got the positive test results; Low grade fever; Congestions; Achiness; Loss of taste and smell; Loss of taste and smell; Headache; Itchiness; This is a spontaneous report from a contactable consumer. A 44-years-old female patient received BNT162B2 (COMIRNATY, solution for injection; Batch/Lot Number: ER8732),via an unspecified route of administration, administered in Arm Left on 04Apr2021 15:00 (Batch/Lot Number: ER8732) as DOSE 2, SINGLE and first dose of BNT162B2 (COMIRNATY, solution for injection; Batch/Lot Number: EN6208),via an unspecified route of administration, administered in Arm Left on 14Mar2021 as DOSE 1, SINGLE for covid-19 immunisation(at the age of 44 years). None medical history. No Prior Vaccinations within 4 weeks. No Adverse events following prior vaccinations. There were no concomitant medications. The patient experienced breakthrough covid-19 on an unspecified date, breakthrough covid-19/she got the positive test results on 12Oct2021, itchiness on Oct2021 with outcome of unknown , low grade fever on 12Oct2021, congestions on 12Oct2021, headache on Oct2021, achiness on 12Oct2021, loss of taste and smell on Oct2021.The patient underwent lab tests and procedures which included body temperature: 100 on 12Oct2021, body temperature: 101.1 on 13Oct2021, sars-cov-2 test: positive on 12Oct2021. It was reported that she was fully vaccinated on 04Apr2021 of this year. She had a breakthrough case of Covid last month and had mild symptoms. She had a mild fever that lasted for like 2 days and it was like 100 degrees, it was 101.1 and it was very mild. She had achiness and congestion. The congestion lasted probably like 10 to 12 days. She lost her sense of taste and smell. Clarified that all of these symptoms occurred last month in Oct2021. Caller states that it was 10Oct2021 or 12Oct2021. She got the positive test results 12Oct2021 and started to feel symptoms for Covid. Clarified that it was a PCR test because she was supposed to travel and did the test 2 days prior to traveling. Caller stated that the achiness and low grade fever occurred 12Oct2021 and 13Oct2021. She states that some time on 13Oct2021 or 14Oct2021, she lost her sense of taste and smell. She was congested for about 10 to 12 days. She had a headache probably every day. She states that she can't say definitively that it was due to Covid but she gets headaches every day anyways, in general. She took lozenges but, she didn't really take anything. The clinical outcome of the events was recovered for nasal congestion, pyrexia, on unspecified date in Oct2021 and for all other events it was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information was expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pain, Pruritus, Pyrexia, SARS-CoV-2 test
Clinical narrative: Breakthrough COVID-19; Breakthrough COVID-19/She got the positive test results; Low grade fever; Congestions; Achiness; Loss of taste and smell; Loss of taste and smell; Headache; Itchiness; This is a spontaneous report from a contactable consumer. A 44-years-old female patient received BNT162B2 (COMIRNATY, solution for injection; Batch/Lot Number: ER8732),via an unspecified route of administration, administered in Arm Left on 04Apr2021 15:00 (Batch/Lot Number: ER8732) as DOSE 2, SINGLE and first dose of BNT162B2 (COMIRNATY, solution for injection; Batch/Lot Number: EN6208),via an unspecified route of administration, administered in Arm Left on 14Mar2021 as DOSE 1, SINGLE for covid-19 immunisation(at the age of 44 years). None medical history. No Prior Vaccinations within 4 weeks. No Adverse events following prior vaccinations. There were no concomitant medications. The patient experienced breakthrough covid-19 on an unspecified date, breakthrough covid-19/she got the positive test results on 12Oct2021, itchiness on Oct2021 with outcome of unknown , low grade fever on 12Oct2021, congestions on 12Oct2021, headache on Oct2021, achiness on 12Oct2021, loss of taste and smell on Oct2021.The patient underwent lab tests and procedures which included body temperature: 100 on 12Oct2021, body temperature: 101.1 on 13Oct2021, sars-cov-2 test: positive on 12Oct2021. It was reported that she was fully vaccinated on 04Apr2021 of this year. She had a breakthrough case of Covid last month and had mild symptoms. She had a mild fever that lasted for like 2 days and it was like 100 degrees, it was 101.1 and it was very mild. She had achiness and congestion. The congestion lasted probably like 10 to 12 days. She lost her sense of taste and smell. Clarified that all of these symptoms occurred last month in Oct2021. Caller states that it was 10Oct2021 or 12Oct2021. She got the positive test results 12Oct2021 and started to feel symptoms for Covid. Clarified that it was a PCR test because she was supposed to travel and did the test 2 days prior to traveling. Caller stated that the achiness and low grade fever occurred 12Oct2021 and 13Oct2021. She states that some time on 13Oct2021 or 14Oct2021, she lost her sense of taste and smell. She was congested for about 10 to 12 days. She had a headache probably every day. She states that she can't say definitively that it was due to Covid but she gets headaches every day anyways, in general. She took lozenges but, she didn't really take anything. The clinical outcome of the events was recovered for nasal congestion, pyrexia, on unspecified date in Oct2021 and for all other events it was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information was expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination failure
Clinical narrative: Breakthrough COVID-19; Breakthrough COVID-19/She got the positive test results; Low grade fever; Congestions; Achiness; Loss of taste and smell; Loss of taste and smell; Headache; Itchiness; This is a spontaneous report from a contactable consumer. A 44-years-old female patient received BNT162B2 (COMIRNATY, solution for injection; Batch/Lot Number: ER8732),via an unspecified route of administration, administered in Arm Left on 04Apr2021 15:00 (Batch/Lot Number: ER8732) as DOSE 2, SINGLE and first dose of BNT162B2 (COMIRNATY, solution for injection; Batch/Lot Number: EN6208),via an unspecified route of administration, administered in Arm Left on 14Mar2021 as DOSE 1, SINGLE for covid-19 immunisation(at the age of 44 years). None medical history. No Prior Vaccinations within 4 weeks. No Adverse events following prior vaccinations. There were no concomitant medications. The patient experienced breakthrough covid-19 on an unspecified date, breakthrough covid-19/she got the positive test results on 12Oct2021, itchiness on Oct2021 with outcome of unknown , low grade fever on 12Oct2021, congestions on 12Oct2021, headache on Oct2021, achiness on 12Oct2021, loss of taste and smell on Oct2021.The patient underwent lab tests and procedures which included body temperature: 100 on 12Oct2021, body temperature: 101.1 on 13Oct2021, sars-cov-2 test: positive on 12Oct2021. It was reported that she was fully vaccinated on 04Apr2021 of this year. She had a breakthrough case of Covid last month and had mild symptoms. She had a mild fever that lasted for like 2 days and it was like 100 degrees, it was 101.1 and it was very mild. She had achiness and congestion. The congestion lasted probably like 10 to 12 days. She lost her sense of taste and smell. Clarified that all of these symptoms occurred last month in Oct2021. Caller states that it was 10Oct2021 or 12Oct2021. She got the positive test results 12Oct2021 and started to feel symptoms for Covid. Clarified that it was a PCR test because she was supposed to travel and did the test 2 days prior to traveling. Caller stated that the achiness and low grade fever occurred 12Oct2021 and 13Oct2021. She states that some time on 13Oct2021 or 14Oct2021, she lost her sense of taste and smell. She was congested for about 10 to 12 days. She had a headache probably every day. She states that she can't say definitively that it was due to Covid but she gets headaches every day anyways, in general. She took lozenges but, she didn't really take anything. The clinical outcome of the events was recovered for nasal congestion, pyrexia, on unspecified date in Oct2021 and for all other events it was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information was expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Headache, Menstrual disorder
Clinical narrative: This is a spontaneous report from contactable nurse. This is the second of 2 reports. This 45-years-old nurse (Patient) reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 23Sep2021 (at the age of 45 years) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bystolic and experienced allergy, bnt162b2 (Pfizer Covid -19 Vaccine) at left arm as dose 1, single on 02Sep2021 (at the age of 45 years) for covid-19 immunisation and experienced fatigue for 3 weeks, mental fog for 3 days, feeling of someone ringing out her heart and lungs like a wet washcloth for 1 day, sore left arm. Facility where the most recent COVID-19 vaccine was administered was available. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in 2021 (after dose 2), she had fatigue for 3 weeks, fever for 8 days, muscle pain for 8 days, joint pain for 8 days, hurt to touch her skin for 5 days, headache for 8 days, shortness of breath for 5 days, heart palpitations for 8 days, nausea for 8 days, period for 1 month, sore left arm. No hospitalization was prolonged. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The seriousness of events was non-serious. Treatment received was Advil and Tylenol. The outcome of events was recovered on unspecified dates in 2021.Device Date : 13Nov2021. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain in extremity, Pain of skin, Palpitations
Clinical narrative: This is a spontaneous report from contactable nurse. This is the second of 2 reports. This 45-years-old nurse (Patient) reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 23Sep2021 (at the age of 45 years) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bystolic and experienced allergy, bnt162b2 (Pfizer Covid -19 Vaccine) at left arm as dose 1, single on 02Sep2021 (at the age of 45 years) for covid-19 immunisation and experienced fatigue for 3 weeks, mental fog for 3 days, feeling of someone ringing out her heart and lungs like a wet washcloth for 1 day, sore left arm. Facility where the most recent COVID-19 vaccine was administered was available. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in 2021 (after dose 2), she had fatigue for 3 weeks, fever for 8 days, muscle pain for 8 days, joint pain for 8 days, hurt to touch her skin for 5 days, headache for 8 days, shortness of breath for 5 days, heart palpitations for 8 days, nausea for 8 days, period for 1 month, sore left arm. No hospitalization was prolonged. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The seriousness of events was non-serious. Treatment received was Advil and Tylenol. The outcome of events was recovered on unspecified dates in 2021.Device Date : 13Nov2021. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This is a spontaneous report from contactable nurse. This is the second of 2 reports. This 45-years-old nurse (Patient) reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 23Sep2021 (at the age of 45 years) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bystolic and experienced allergy, bnt162b2 (Pfizer Covid -19 Vaccine) at left arm as dose 1, single on 02Sep2021 (at the age of 45 years) for covid-19 immunisation and experienced fatigue for 3 weeks, mental fog for 3 days, feeling of someone ringing out her heart and lungs like a wet washcloth for 1 day, sore left arm. Facility where the most recent COVID-19 vaccine was administered was available. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in 2021 (after dose 2), she had fatigue for 3 weeks, fever for 8 days, muscle pain for 8 days, joint pain for 8 days, hurt to touch her skin for 5 days, headache for 8 days, shortness of breath for 5 days, heart palpitations for 8 days, nausea for 8 days, period for 1 month, sore left arm. No hospitalization was prolonged. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The seriousness of events was non-serious. Treatment received was Advil and Tylenol. The outcome of events was recovered on unspecified dates in 2021.Device Date : 13Nov2021. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Choking sensation, Cough, Epistaxis, Fatigue, Feeling abnormal
Clinical narrative: she reports feeling wiped out all day and then today she is still not feeling herself; tired; blood clots hanging in the back of her throat; feel like she was choking; horrific nose bleed; blood clots hanging in the back of her throat were making her cough; This is a spontaneous report from a contactable consumer (patient).   A 71-years-old female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number: Not reported), dose 3 via an unspecified route of administration on Apr2021 10:00 as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced blood clots hanging in the back of her throat, feel like she was choking, horrific nose bleed, blood clots hanging in the back of her throat were making her cough, on 13Nov2021. she reports feeling wiped out all day and then today she is still not feeling herself and tired on 14Nov2021. female who receieved her primary series of the Pfizer BioNtech covid 19 vaccine back in April. Last Thursday around 10 am she receieved her booster dose. Then on Saturday evening she experienced a horrific nose bleed, she normally does not have nose bleeds. The caller described it as very difficult, it took an hour and a half on the phone with a nurse before it slowed down any and 4+ hours before it finally stopped. Caller stated that the experience on Saturday night was grueling that the blood clots hanging in the back of her throat were making her cough and feel like she was choking. The next day on Sunday she reports feeling wiped out all day and then today she is still not feeling herself, tired. Are nose bleeds a side effect from the vaccine?The outcome of blood clots hanging in the back of her throat, feel like she was choking, horrific nose bleed, blood clots hanging in the back of her throat were making her cough, tired was unknown and the outcome of she reports feeling wiped out all day and then today she is still not feeling herself was not recovered. horrific nose bleed was recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up (17Nov2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: she reports feeling wiped out all day and then today she is still not feeling herself; tired; blood clots hanging in the back of her throat; feel like she was choking; horrific nose bleed; blood clots hanging in the back of her throat were making her cough; This is a spontaneous report from a contactable consumer (patient).   A 71-years-old female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number: Not reported), dose 3 via an unspecified route of administration on Apr2021 10:00 as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced blood clots hanging in the back of her throat, feel like she was choking, horrific nose bleed, blood clots hanging in the back of her throat were making her cough, on 13Nov2021. she reports feeling wiped out all day and then today she is still not feeling herself and tired on 14Nov2021. female who receieved her primary series of the Pfizer BioNtech covid 19 vaccine back in April. Last Thursday around 10 am she receieved her booster dose. Then on Saturday evening she experienced a horrific nose bleed, she normally does not have nose bleeds. The caller described it as very difficult, it took an hour and a half on the phone with a nurse before it slowed down any and 4+ hours before it finally stopped. Caller stated that the experience on Saturday night was grueling that the blood clots hanging in the back of her throat were making her cough and feel like she was choking. The next day on Sunday she reports feeling wiped out all day and then today she is still not feeling herself, tired. Are nose bleeds a side effect from the vaccine?The outcome of blood clots hanging in the back of her throat, feel like she was choking, horrific nose bleed, blood clots hanging in the back of her throat were making her cough, tired was unknown and the outcome of she reports feeling wiped out all day and then today she is still not feeling herself was not recovered. horrific nose bleed was recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up (17Nov2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test normal, Epistaxis, Mouth haemorrhage, Platelet count normal, Thrombosis
Clinical narrative: she reports feeling wiped out all day and then today she is still not feeling herself; tired; blood clots hanging in the back of her throat; feel like she was choking; horrific nose bleed; blood clots hanging in the back of her throat were making her cough; This is a spontaneous report from a contactable consumer (patient).   A 71-years-old female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number: Not reported), dose 3 via an unspecified route of administration on Apr2021 10:00 as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced blood clots hanging in the back of her throat, feel like she was choking, horrific nose bleed, blood clots hanging in the back of her throat were making her cough, on 13Nov2021. she reports feeling wiped out all day and then today she is still not feeling herself and tired on 14Nov2021. female who receieved her primary series of the Pfizer BioNtech covid 19 vaccine back in April. Last Thursday around 10 am she receieved her booster dose. Then on Saturday evening she experienced a horrific nose bleed, she normally does not have nose bleeds. The caller described it as very difficult, it took an hour and a half on the phone with a nurse before it slowed down any and 4+ hours before it finally stopped. Caller stated that the experience on Saturday night was grueling that the blood clots hanging in the back of her throat were making her cough and feel like she was choking. The next day on Sunday she reports feeling wiped out all day and then today she is still not feeling herself, tired. Are nose bleeds a side effect from the vaccine?The outcome of blood clots hanging in the back of her throat, feel like she was choking, horrific nose bleed, blood clots hanging in the back of her throat were making her cough, tired was unknown and the outcome of she reports feeling wiped out all day and then today she is still not feeling herself was not recovered. horrific nose bleed was recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up (17Nov2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Passed away after taking the 2 first vaccines covid vaccines; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single, and via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history and concomitant medications were not reported. It was reported that the patient passed away after taking the 2 first vaccines COVID vaccines on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Passed away after taking the 2 first vaccines covid vaccines
Sex: U
Vaccine: COVID19
Symptoms: Renal disorder
Clinical narrative: She know somebody with kidney problems; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced kidney problems. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Nephrotic syndrome, Overdose
Clinical narrative: overdose; One of my twins have nephrotic syndrome; This is a spontaneous report from a contactable consumer (parent). A 7-year-old female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration on 09Nov2021 (at age of 7-year-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced one of my twins have nephrotic syndrome (medically significant) on an unspecified date in 2021, the pedestrian accidently gave them both adult vaccine dose instead the age appropriate dose on 09Nov2021. The outcome of events was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blood test, Chest pain, Dyspnoea, Heart rate increased
Clinical narrative: This is a spontaneous report from a contactable consumer. This 45-year-old female patient (consumer) reported for herself that she received first dose of bnt162b2 (Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in upper left arm on 12Nov2021 at 14:15 (at the age of 45 years) as dose 1, single for covid-19 immunisation. Pregnancy at time of Vaccination: No. Medical history included ongoing rheumatoid arthritis in 1997. No known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. There were no concomitant medications. Facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Facility type vaccine: other Mobile clinic bus. On 12Nov2021 at 19:00, she had muscle and back pain the evening of vaccine and had chest pain. Thought it was a pinched nerve but continued into the next two days and two days after she still had chest pain making it hard to take a deep breathe and then had rapid heart rate. She went to emergency room//department or urgent care (ER) on 14Nov2021. On an unspecified date in 2021, patient experienced internal inflammation. No hospitalization was prolonged. The events were non-serious. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included blood test: unknown on 12Nov2021. The patient received medication which included medicine for internal inflammation, blood work. The outcome of event internal inflammation was unknown while the outcome of other events was recovering. Device timestamp: 15Nov2021.The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow up. The patient experienced muscle and back pain (myalgia) (non-serious) on 12Nov2021 19:00 with outcome of recovering , muscle and back pain (back pain) (non-serious) on 12Nov2021 19:00 with outcome of recovering , chest pain (chest pain) (non-serious) on 12Nov2021 19:00 with outcome of recovering , thought it was a pinched nerve (nerve compression) (non-serious) on 12Nov2021 19:00 with outcome of recovering , hard to take a deep breathe (dyspnoea) (non-serious) on 12Nov2021 19:00 with outcome of recovering , had rapid heart rate (heart rate increased) (non-serious) on 12Nov2021 19:00 with outcome of recovering , medical internal inflammation (inflammation) (non-serious) on an unspecified date with outcome of unknown. The action taken in response to the event(s) for bnt162b2 was not applicable.  Therapeutic measures were taken as a result of muscle and back pain (myalgia), muscle and back pain (back pain), chest pain (chest pain), thought it was a pinched nerve (nerve compression), hard to take a deep breathe (dyspnoea) , had rapid heart rate (heart rate increased). The events were non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Myalgia, Nerve compression, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer. This 45-year-old female patient (consumer) reported for herself that she received first dose of bnt162b2 (Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in upper left arm on 12Nov2021 at 14:15 (at the age of 45 years) as dose 1, single for covid-19 immunisation. Pregnancy at time of Vaccination: No. Medical history included ongoing rheumatoid arthritis in 1997. No known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. There were no concomitant medications. Facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Facility type vaccine: other Mobile clinic bus. On 12Nov2021 at 19:00, she had muscle and back pain the evening of vaccine and had chest pain. Thought it was a pinched nerve but continued into the next two days and two days after she still had chest pain making it hard to take a deep breathe and then had rapid heart rate. She went to emergency room//department or urgent care (ER) on 14Nov2021. On an unspecified date in 2021, patient experienced internal inflammation. No hospitalization was prolonged. The events were non-serious. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included blood test: unknown on 12Nov2021. The patient received medication which included medicine for internal inflammation, blood work. The outcome of event internal inflammation was unknown while the outcome of other events was recovering. Device timestamp: 15Nov2021.The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow up. The patient experienced muscle and back pain (myalgia) (non-serious) on 12Nov2021 19:00 with outcome of recovering , muscle and back pain (back pain) (non-serious) on 12Nov2021 19:00 with outcome of recovering , chest pain (chest pain) (non-serious) on 12Nov2021 19:00 with outcome of recovering , thought it was a pinched nerve (nerve compression) (non-serious) on 12Nov2021 19:00 with outcome of recovering , hard to take a deep breathe (dyspnoea) (non-serious) on 12Nov2021 19:00 with outcome of recovering , had rapid heart rate (heart rate increased) (non-serious) on 12Nov2021 19:00 with outcome of recovering , medical internal inflammation (inflammation) (non-serious) on an unspecified date with outcome of unknown. The action taken in response to the event(s) for bnt162b2 was not applicable.  Therapeutic measures were taken as a result of muscle and back pain (myalgia), muscle and back pain (back pain), chest pain (chest pain), thought it was a pinched nerve (nerve compression), hard to take a deep breathe (dyspnoea) , had rapid heart rate (heart rate increased). The events were non-serious.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Breast swelling, Chills, Dizziness
Clinical narrative: Sore arm; Fatigue; Light headed within 6 h; Cold hands; Mild chill 12h after injection severe chill started 18h after injection & lasted about 5 hours; Muscle aches; Sore and swelling armpit and breast same site as the injection site; Sore and swelling armpit and breast same site as the injection site; Sore and swelling armpit and breast same site as the injection site; Sore and swelling armpit and breast same site as the injection site; The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 33026BD) via an unspecified route of administration in left arm on 10Nov2021 at 19:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included perimenopause. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included estradiol (MANUFACTURER UNKNOWN) and norethisterone acetate (NORETHINDRONE ACETATE); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 53-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 11Nov2021, the patient experienced sore arm, fatigue, light headed within 6 hours, cold hands and mild chill approximately 12 hours after injection, muscle aches and severe chill started approximately 18h after injection & lasted approximately 5 hours, sore & swelling armpit and breast same site as the injection arm started approximately 18h after injection and persist at the time of submitting this report. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event mild chill approximately 12hours after injection, severe chill started approximately 18h after injection & lasted approximately 5 hours was resolved on 11Nov2021 and sore arm, fatigue, light headed within 6 hours, cold hands, muscle aches, sore & swelling armpit and breast same site as the injection arm started approximately 18h after injection was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.